We have developed human iPSC-derived motor neuron progenitors from both healthy and patient donors, which can be cultured in vitro to provide a physiologically relevant alternative to conventional animal-derived models for use in proof-of principle drug-screening assays and for modelling motor neuron degeneration.
Axol’s human iPSC-derived motor neuron progenitors have been differentiated using a combination of small molecules to generate a near pure population of terminally differentiated mature functional motor neurons.
We specifically developed Motor Neuron Recovery Medium which supports cell recovery after thawing and initial progenitor cell expansion, as well as Motor Neuron Maintenance Medium which promotes the optimal differentiation and maturation of the progenitors to functional motor neurons.